0001517026-21-000003.txt : 20210826
0001517026-21-000003.hdr.sgml : 20210826
20210826215510
ACCESSION NUMBER: 0001517026-21-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210825
FILED AS OF DATE: 20210826
DATE AS OF CHANGE: 20210826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verratti Mark
CENTRAL INDEX KEY: 0001517026
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 211213997
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SATL LAKE CITY
STATE: UT
ZIP: 84003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-25
0
0000899923
MYRIAD GENETICS INC
MYGN
0001517026
Verratti Mark
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
President, Myriad Neuroscience
Common Stock
2021-08-25
4
F
0
1082
34.81
D
156048
D
Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2021.
By: Nathan A. Smith For: Mark Verratti
2021-08-26